Tianjin Lisheng Pharmaceutical (002393.SZ) has received the registration certificate for Fluconazole tablets.
Livzon Pharmaceutical (002393.SZ) announced that the company has received the "Drug Registration Certificate" for the 0.2g specification of Fudeconazole tablets and the "Drug Registration Certificate" for the 50mg specification of Fudeconazole tablets issued by the National Medical Products Administration. The above-mentioned drugs have passed the drug market authorization application. Fudeconazole tablets are a broad-spectrum triazole antifungal drug.
Tianjin Lisheng Pharmaceutical (002393.SZ) announced that the company has received the "Drug Registration Certificate" for the 0.2g specification of Fulekangzuo tablets and the "Drug Registration Certificate" for the 50mg specification of Fulekangzuo tablets issued by the National Medical Products Administration. The above-mentioned drugs have passed the drug market approval application. Fulekangzuo tablets are a broad-spectrum triazole antifungal drug.
Related Articles
ANDRE JUICE (02218): Li Yufeng has been appointed to replace Yu Haifeng as the signing registered accountant.
SIIC Environment (00807) will distribute a final dividend of 0.011 Singapore dollars per share on May 29th.
Shenwan Hongyuan Group (06806): "22 Shen Hong 02" will pay interest on March 9th.
ANDRE JUICE (02218): Li Yufeng has been appointed to replace Yu Haifeng as the signing registered accountant.
SIIC Environment (00807) will distribute a final dividend of 0.011 Singapore dollars per share on May 29th.
Shenwan Hongyuan Group (06806): "22 Shen Hong 02" will pay interest on March 9th.
RECOMMEND
